Recalls · Brand

Merck & Co. Inc recalls

Every recall we track for Merck & Co. Inc — 5 in all — plus the complaints and injury reports the public filed about them.

5recalls

11complaints & reports

4injuries reported

All Merck & Co. Inc recalls

5 shown

✓ Lower riskDrug
Merck & Co. Inc recalls Belsomra (suvorexant) tablets, 10mg, 30 Tablets in 3 Blister Cards per Carton, Each Blister Card contains 10 Tablets,
Merck recalls Belsomra 10mg tablets due to potential delayed drug release, risking sleep onset delays. Affected lots: 2090019 and 2123744, expiring 4/30/2027. No remedy specified.
MerckJul 21, 2025
ℹ️ UnratedDrug
Merck & Co Inc recalls Liptruzet (ezetimibe and atorvastin) tablets,10 mg/80 mg, a) 30 count blister (NDC 66582-323-30), b) 90 count blister
Merck & Co. IncJan 13, 2014
ℹ️ UnratedDrug
Merck & Co Inc recalls Liptruzet (ezetimibe and atorvastin) tablets,10 mg/10 mg, a) 30 count blister (NDC 66582-320-30), b) 90 count blister
Merck & Co. IncJan 13, 2014
ℹ️ UnratedDrug
Merck & Co Inc recalls Liptruzet (ezetimibe and atorvastin) tablets,10 mg/20 mg, a) 30 count blister (NDC 66582-321-30), b) 90 count blister
Merck & Co. IncJan 13, 2014
ℹ️ UnratedDrug
Merck & Co Inc recalls Liptruzet (ezetimibe and atorvastin) tablets,10 mg/40 mg, a) 30 count blister (NDC 66582-322-30), b) 90 count blister
Merck & Co. IncJan 13, 2014